We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in Japan
Price data last checked 150 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 16 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 322 days • 322 data points (No recent data available)
Price Distribution
Price distribution over 322 days • 1 price levels
Price Analysis
Most common price: £495 (322 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 322 days
Product Specifications
- Format
- paperback
- ASIN
- B0BP9S1JLJ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in China
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in India
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India
The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs
The 2023 Report on Anti-Viral Nucleotide Polymerase Inhibitor Drugs: World Market Segmentation by City
The 2023-2028 Outlook for Antiviral Drugs in the United States
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in Japan
The 2023-2028 Outlook for Antiviral Drugs in India
The 2013-2018 Outlook for Systemic Antiviral Pharmaceuticals in India
The 2023-2028 Outlook for Viral Infections in Japan
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States
The 2025-2030 World Outlook for Generic Antiviral Drugs
The 2026-2031 World Outlook for Generic Antiviral Drugs
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in Greater China
The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
The 2023-2028 Outlook for Viral Infections in the United States
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
The 2023-2028 Outlook for Viral Infections in India
The 2023-2028 Outlook for Viral Infections in China
The 2023-2028 Outlook for Pure Generic Drugs in Japan
The 2013-2018 Outlook for Hepatitis C Virus (HCV) Therapeutics in India
The 2023-2028 Outlook for Animal Pharmaceuticals in Japan
